Hangzhou Alltest Biotech Co. Ltd. logo

Hangzhou Alltest Biotech Co. Ltd. (688606)

Market Closed
10 Aug, 06:57
SSE SSE
¥
47. 20
+0.81
+1.7461%
¥
6.47B Market Cap
- P/E Ratio
6% Div Yield
480,019 Volume
- Eps
¥ 46.39
Previous Close
Add Transaction
Day Range
46.22 47.3
Year Range
39.8 78.2
Want to track 688606 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688606 closed yesterday higher at ¥47.2, an increase of 1.7461% from Friday's close, completing a monthly increase of 13.8172% or ¥5.73. Over the past 12 months, 688606 stock lost -25.6693%.
688606 pays dividends to its shareholders, with the most recent payment made on Jun 01, 2026. The next estimated payment will be in In 3 months on Dec 01, 2026 for a total of ¥1.
The last earnings report, released on May 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Hangzhou Alltest Biotech Co. Ltd. has completed 1 stock splits, with the recent split occurring on Jun 09, 2023.
The company's stock is traded on one exchange.

688606 Chart

People also search for

Beijing Teamsun Technology Co., Ltd.
¥ 15.65
-0.2549%
Insigma Technology Co. Ltd.
¥ 7.57
+1.4745%
Henan Thinker Automatic Equipment Co., Ltd.
¥ 22.06
-0.181%
Beijing Yuanliu Hongyuan Electronic Technology Co., Ltd.
¥ 52.83
+1.7527%
Xgimi Technology Co., Ltd.
¥ 75.16
+1.9672%

Hangzhou Alltest Biotech Co. Ltd. (688606) FAQ

What is the stock price today?

The current price is ¥47.20.

On which exchange is it traded?

Hangzhou Alltest Biotech Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688606.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6%.

What is its market cap?

As of today, the market cap is 6.47B.

Has Hangzhou Alltest Biotech Co. Ltd. ever had a stock split?

Hangzhou Alltest Biotech Co. Ltd. had 1 splits and the recent split was on Jun 09, 2023.

Hangzhou Alltest Biotech Co. Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Fei Gao CEO
SSE Exchange
CNE1000053G6 ISIN
CN Country
1,093 Employees
1 Jun 2026 Last Dividend
9 Jun 2023 Last Split
- IPO Date

Overview

Founded in 2009 and headquartered in Hangzhou, China, Hangzhou Alltest Biotech Co., Ltd. is a prominent entity in the biotechnological sector, primarily focusing on the research, development, production, and sale of in vitro diagnostic reagents. The company caters to both the domestic Chinese market and an international clientele, reflecting its broad reach in the healthcare industry. Specializing in rapid diagnostic reagents, Hangzhou Alltest Biotech is dedicated to providing advanced solutions for clinical testing, on-site testing, personal health management, and other specialized fields, thereby contributing significantly to the improvement of global healthcare standards.

Products and Services

COVID-19 Antigen and Antibody Tests: High-accuracy tests designed for the detection of SARS-CoV-2, critical for managing and controlling the COVID-19 pandemic. These tests are essential for both clinical diagnosis and epidemiological surveys.

Veterinary Tests: Comprehensive diagnostic solutions catering to the veterinary field, enabling rapid and accurate disease detection in animals. These tests play a crucial role in ensuring animal health and preventing zoonotic diseases.

Fluorescence Immunoassay Tests and Analyzers: Advanced testing equipment and reagents for the sensitive and specific detection of various biomarkers, using fluorescence immunoassay technology. These products are widely used in the diagnosis of infectious diseases, hormone imbalances, and other health conditions.

Urine Analysis Solutions: In-depth diagnostic tools for analyzing urine samples, providing valuable information on renal function, urinary tract infections, and other metabolic disorders.

Biochemistry Reagents: A wide range of reagents used for biochemical analyses in laboratories, aiding in the diagnosis and monitoring of disease states through the biochemical assessment of bodily fluids.

VTM (Viral Transport Media): Essential for the safe and reliable transport of virus specimens, maintaining the viability of viral particles from collection to analysis.

Blood Glucose Monitoring Systems: User-friendly devices essential for daily blood glucose management, catering to the needs of diabetic patients by facilitating self-monitoring of blood glucose levels.

HB Hemoglobin Test Meters: Compact, portable devices used for measuring hemoglobin levels, crucial for diagnosing anemia and monitoring patients' hemoglobin status.

SARS-COV-2 RT-qPCR Assays: Highly sensitive and specific laboratory tests that detect the genetic material of SARS-CoV-2, offering a gold standard for COVID-19 diagnosis. These assays play a pivotal role in pandemic response efforts.

Virus Specimen Stabilizers: Chemical solutions designed to preserve the integrity of viral RNA or DNA in specimens, ensuring accurate results in subsequent tests.

Viral DNA/RNA Extraction Kits: Specialized kits providing the necessary materials for the efficient and effective extraction of viral genetic material, facilitating the accurate diagnosis of viral infections.

Contact Information

Address: Building 3, 4, 5, Hangzhou, China, 310018
Phone: 86 57 1562 07860